Research trends and hotspots of upconversion nanoparticles for drug delivery and biomedical targeting in photodynamic therapy
Source abstract
Abstract
AIM: This study presents a bibliometric analysis of research trends and emerging hotspots in upconversion nanoparticles (UCNPs) for drug delivery and biomedical targeting in photodynamic therapy (PDT). METHODS: We retrieved 474 publications from the Web of Science (2007-2025) and analyzed publication trends, contributions from countries, institutions, and authors, keyword co-occurrence, citation bursts, and co-citation networks using CiteSpace, VOSviewer, HistCite, and R software. RESULTS: UCNP-PDT research progressed through three distinct phases, with China and the USA contributing the most publications. Nanoscale published the highest number of articles, while high-impact reviews appeared in Chemical Society Reviews and Advanced Materials. Emerging research focuses include the tumor microenvironment, metal-organic frameworks, combination therapies, and antimicrobial PDT. CONCLUSION: UCNP-PDT has evolved from simple photosensitizer loading to multifunctional nanoplatforms, expanding applications to cancer therapy, infection control, and immune modulation. Clinical translation remains limited by size-efficiency trade-offs, low-power irradiation, hypoxia, tissue heating under 980 nm excitation, GMP-compliant production, and insufficient long-term biosafety data. Future advances require coordinated strategies integrating material optimization, mechanistic insight, and translational considerations to achieve safe, scalable, and effective UCNP-PDT for clinical use.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence Properties of Advanced Materials · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Chandna S, Thakur NS, Kaur R, Bhaumik J. Lignin-bimetallic nanoconjugate doped pH-responsive hydrogels for laser-assisted antimicrobial photodynamic therapy. Biomacromol. 2020;21(8):3216–30. https://doi.org/10.1021/acs.biomac.0c00695.10.1021/acs.biomac.0c00695 ↗
2. Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kedzierska E, Knap-Czop K, et al. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–107. https://doi.org/10.1016/j.biopha.2018.07.049.10.1016/j.biopha.2018.07.049 ↗
3. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McConnick T, et al. Photodynarnic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol. 2007;224(3):290–9. https://doi.org/10.1016/j.taap.2007.01.025.10.1016/j.taap.2007.01.025 ↗
4. Chen LY, Lin YX, Ding SL, Huang MD, Jiang LG. Recent advances in clinically used and trialed photosensitizers for antitumor photodynamic therapy. Mol Pharm. 2025;22(7):3530–41. https://doi.org/10.1021/acs.molpharmaceut.5c00110.10.1021/acs.molpharmaceut.5c00110 ↗
5. Yu Y, Wang N, Wang YY, Shi QL, Yu R, Gu BH, et al. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2023. https://doi.org/10.1016/j.pdpdt.2023.103318.10.1016/j.pdpdt.2023.103318 ↗
6. Hu CJ, Luo XY, Jiang CF, Lei SR, Sun YM. Efficacy and safety of photodynamic therapy for the treatment of actinic keratoses: a meta-analysis update of randomized controlled trials. Dermatol Surg. 2023;49(6):544–51. https://doi.org/10.1097/DSS.0000000000003784.10.1097/DSS.0000000000003784 ↗
7. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.10.3322/caac.21834 ↗
8. Cai YY, Chai T, Nguyen W, Liu JY, Xiao EH, Ran X, et al. Phototherapy in cancer treatment: strategies and challenges. Signal Transduct Target Ther. 2025. https://doi.org/10.1038/s41392-025-02140-y.10.1038/s41392-025-02140-y ↗
9. Allison RR. Photodynamic therapy: oncologic horizons. Future Oncol. 2014;10(1):123–42. https://doi.org/10.2217/FON.13.176.10.2217/FON.13.176 ↗
10. Ogawa E, Akimoto J, Fukami S, Hayashi S, Kohno M, Doi M, et al. Diffused light attenuation at 664 nm for PDT in salted cadaver brain. Photodiagnosis Photodyn Ther. 2020. https://doi.org/10.1016/j.pdpdt.2019.101593.10.1016/j.pdpdt.2019.101593 ↗
11. Akimoto J, Fukami S, Suda T, Ichikawa M, Haraoka R, Kohno M, et al. First autopsy analysis of the efficacy of intra-operative additional photodynamic therapy for patients with glioblastoma. Brain Tumor Pathol. 2019;36(4):144–51. https://doi.org/10.1007/s10014-019-00351-0.10.1007/s10014-019-00351-0 ↗
12. Chatterjee DK, Yong Z. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine. 2008;3(1):73–82. https://doi.org/10.2217/17435889.3.1.73.10.2217/17435889.3.1.73 ↗
13. Liang GF, Wang HJ, Shi H, Wang HT, Zhu MX, Jing AH, et al. Recent progress in the development of upconversion nanomaterials in bioimaging and disease treatment. J Nanobiotechnol. 2020. https://doi.org/10.1186/s12951-020-00713-3.10.1186/s12951-020-00713-3 ↗
14. del Valle CA, Hirsch T, Marín MJ. Recent advances in near infrared upconverting nanomaterials for targeted photodynamic therapy of cancer. Methods Appl Fluoresc. 2022. https://doi.org/10.1088/2050-6120/ac6937.10.1088/2050-6120/ac6937 ↗
15. Haase M, Schäfer H. Upconverting nanoparticles. Angew Chem Int Ed. 2011;50(26):5808–29. https://doi.org/10.1002/anie.201005159.10.1002/anie.201005159 ↗
16. Lee JM, Lee H, Kang MC, Baday M, Lee SH. High spatial and temporal resolution using upconversion nanoparticles and femtosecond pulsed laser in single particle tracking. Curr Appl Phys. 2022;44:40–5. https://doi.org/10.1016/j.cap.2022.09.002.10.1016/j.cap.2022.09.002 ↗
17. Gnach A, Lipinski T, Bednarkiewicz A, Rybka J, Capobianco JA. Upconverting nanoparticles: assessing the toxicity. Chem Soc Rev. 2015;44(6):1561–84. https://doi.org/10.1039/c4cs00177j.10.1039/c4cs00177j ↗
18. Sun J, Song LJ, Fan Y, Tian LM, Luan SF, Niu SC, et al. Synergistic photodynamic and photothermal antibacterial nanocomposite membrane triggered by single NIR light source. ACS Appl Mater Interfaces. 2019;11(30):26581–9. https://doi.org/10.1021/acsami.9b07037.10.1021/acsami.9b07037 ↗
19. Hou ZY, Zhang YX, Deng KR, Chen YY, Li XJ, Deng XR, et al. UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway. ACS Nano. 2015;9(3):2584–99. https://doi.org/10.1021/nn506107c.10.1021/nn506107c ↗
20. Mukherjee P, Guha S, Das G, Samui A, Sahu SK. NIR light-activated upconversion POP nanofiber composite; an effective carrier for targeted photodynamic therapy and drug delivery. J Photochem Photobiol A Chem. 2023. https://doi.org/10.1016/j.jphotochem.2023.114907.10.1016/j.jphotochem.2023.114907 ↗
21. Shapoval O, Patsula V, Vetvicka D, Engstová H, Oleksa V, Kabesová M, et al. Temoporfin-conjugated pegylated poly(N, N-dimethylacrylamide)-coated upconversion colloid for NIR-induced photodynamic therapy of pancreatic cancer. Biomacromol. 2024;25(9):5771–85. https://doi.org/10.1021/acs.biomac.4c00317.10.1021/acs.biomac.4c00317 ↗
22. Fan ZY, Zhang YM, Shao YH, Jiang X, Ye YF, Zhou JL, et al. Alginate-functionalized and 4T1 cell membrane-coated multi-tasking nanoparticulate system for near-infrared-triggered photodynamic therapy on breast cancer: in vitro cellular and in vivo mice models. Compos Commun. 2024. https://doi.org/10.1016/j.coco.2024.102066.10.1016/j.coco.2024.102066 ↗
23. Li CA, Nan JJ, Ye QX, Zheng BZ, Dai XM, Li JY, et al. Amplifying anti‐tumor immune responses via mitochondria‐targeting near‐infrared photodynamic therapy. Adv Sci. 2025. https://doi.org/10.1002/advs.202505525.10.1002/advs.202505525 ↗
24. Zhang J, Liu CL, Liu JJ, Bai XH, Cao ZK, Yang J, et al. Eluting mode of photodynamic nanofibers without photosensitizer leakage for one-stop treatment of outdoor hemostasis and sterilizing superbacteria. Nanoscale. 2021;13(12):6105–16. https://doi.org/10.1039/d1nr00179e.10.1039/d1nr00179e ↗
25. Li DQ, Ren JL, Li J, Zhang YM, Lou YC, Zhu JJ, et al. Ferroptosis-apoptosis combined anti-melanoma immunotherapy with a NIR-responsive upconverting mSiO2 photodynamic platform. Chem Eng J. 2021. https://doi.org/10.1016/j.cej.2021.129557.10.1016/j.cej.2021.129557 ↗
26. Zhang YX, Huang P, Wang D, Chen JC, Liu WZ, Hu P, et al. Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles. Nanoscale. 2018;10(33):15485–95. https://doi.org/10.1039/c8nr01967c.10.1039/c8nr01967c ↗
27. Qi ML, Li X, Sun XL, Li CY, Tay FR, Weir MD, et al. Novel nanotechnology and near-infrared photodynamic therapy to kill periodontitis-related biofilm pathogens and protect the periodontium. Dent Mater. 2019;35(11):1665–81. https://doi.org/10.1016/j.dental.2019.08.115.10.1016/j.dental.2019.08.115 ↗
28. Yan EVL, Kwek G, Qing NS, Lingesh S, Xing BA. Antimicrobial photodynamic therapy for the remote eradication of bacteria. ChemPlusChem. 2023. https://doi.org/10.1002/cplu.202300009.10.1002/cplu.202300009 ↗
29. Ad N, Oron U. Impact of low level laser irradiation on infarct size in the rat following myocardial infarction. Int J Cardiol. 2001;80(2–3):109–16. https://doi.org/10.1016/S0167-5273(01)00503-4.10.1016/S0167-5273(01)00503-4 ↗
30. Chen ZW, Liu Z, Li ZH, Ju EG, Gao N, Zhou L, et al. Upconversion nanoprobes for efficiently in vitro imaging reactive oxygen species and in vivo diagnosing rheumatoid arthritis. Biomaterials. 2015;39:15–22. https://doi.org/10.1016/j.biomaterials.2014.10.066.10.1016/j.biomaterials.2014.10.066 ↗
31. Yeung AWK. Comparison between Scopus, Web of Science, Pubmed and publishers for mislabelled review papers. Curr Sci. 2019;116(11):1909. https://doi.org/10.18520/cs/v116/i11/1909-1914.10.18520/cs/v116/i11/1909-1914 ↗
32. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat. 1996;5(3):299–314. https://doi.org/10.2307/1390807.10.2307/1390807 ↗
33. Garfield E, Paris SW, Stock WG. Histcite™: a software tool for informetric analysis of citation linkage. Inf-Wissenschaft und Praxis. 2006;57:391–400.
34. van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–38. https://doi.org/10.1007/s11192-009-0146-3.10.1007/s11192-009-0146-3 ↗
35. Chen C. Citespace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57(3):359–77. https://doi.org/10.1002/asi.20317.10.1002/asi.20317 ↗
36. Thulasi K, Arunachalam S. Mapping of cholera research in India using Histcite. Ann Libr Inf Stud. 2010;57:310–26.
37. Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci U S A. 2005;102(46):16569–72. https://doi.org/10.1073/pnas.0507655102.10.1073/pnas.0507655102 ↗
38. Idris NM, Gnanasammandhan MK, Zhang J, Ho PC, Mahendran R, Zhang Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat Med. 2012;18(10):1580. https://doi.org/10.1038/nm.2933.10.1038/nm.2933 ↗
39. Wang C, Tao HQ, Cheng L, Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials. 2011;32(26):6145–54. https://doi.org/10.1016/j.biomaterials.2011.05.007.10.1016/j.biomaterials.2011.05.007 ↗
40. Chen GY, Qju HL, Prasad PN, Chen XY. Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev. 2014;114(10):5161–214. https://doi.org/10.1021/cr400425h.10.1021/cr400425h ↗
41. Qian HS, Guo HC, Ho PCL, Mahendran R, Zhang Y. Mesoporous‐silica‐coated up‐conversion fluorescent nanoparticles for photodynamic therapy. Small. 2009;5(20):2285–90. https://doi.org/10.1002/smll.200900692.10.1002/smll.200900692 ↗
42. Tian G, Gu ZJ, Zhou LJ, Yin WY, Liu XX, Yan L, et al. Mn2+ dopant‐controlled synthesis of NaYF4:Yb/Er upconversion nanoparticles for in vivo imaging and drug delivery. Adv Mater. 2012;24(9):1226–31. https://doi.org/10.1002/adma.201104741.10.1002/adma.201104741 ↗
43. Xu JT, Yang PP, Sun MD, Bi HT, Liu B, Yang D, et al. Highly emissive dye-sensitized upconversion nanostructure for dual-photosensitizer photodynamic therapy and bioimaging. ACS Nano. 2017;11(4):4133–44. https://doi.org/10.1021/acsnano.7b00944.10.1021/acsnano.7b00944 ↗
44. Chen C, Wu CS, Yu JM, Zhu XH, Wu YH, Liu JL, et al. Photodynamic-based combinatorial cancer therapy strategies: tuning the properties of nanoplatform according to oncotherapy needs. Coord Chem Rev. 2022. https://doi.org/10.1016/j.ccr.2022.214495.10.1016/j.ccr.2022.214495 ↗
45. Lucky SS, Idris NM, Li ZQ, Huang K, Soo KC, Zhang Y. Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano. 2015;9(1):191–205. https://doi.org/10.1021/nn503450t.10.1021/nn503450t ↗
46. Feng LL, Gai SL, Dai YL, He F, Sun CQ, Yang PP, et al. Controllable generation of free radicals from multifunctional heat-responsive nanoplatform for targeted cancer therapy. Chem Mater. 2018;30(2):526–39. https://doi.org/10.1021/acs.chemmater.7b04841.10.1021/acs.chemmater.7b04841 ↗
47. Yang J, Xie R, Feng LL, Liu B, Lv RC, Li CX, et al. Hyperthermia and controllable free radical coenhanced synergistic therapy in hypoxia enabled by near-infrared-II light irradiation. ACS Nano. 2019;13(11):13144–60. https://doi.org/10.1021/acsnano.9b05985.10.1021/acsnano.9b05985 ↗
48. Lv RC, Yang PP, He F, Gai SL, Yang GX, Dai YL, et al. An imaging-guided platform for synergistic photodynamic/photothermal/chemo-therapy with pH/temperature-responsive drug release. Biomaterials. 2015;63:115–27. https://doi.org/10.1016/j.biomaterials.2015.05.016.10.1016/j.biomaterials.2015.05.016 ↗
49. Yang D, Yang GX, Yang PP, Lv RC, Gai SL, Li CX, et al. Assembly of Au plasmonic photothermal agent and iron oxide nanoparticles on ultrathin black phosphorus for targeted photothermal and photodynamic cancer therapy. Adv Funct Mater. 2017. https://doi.org/10.1002/adfm.201700371.10.1002/adfm.201700371 ↗
50. Yang DM, Ma PA, Hou ZY, Cheng ZY, Li CX, Lin J. Current advances in lanthanide ion (Ln3+)-based upconversion nanomaterials for drug delivery. Chem Soc Rev. 2015;44(6):1416–48. https://doi.org/10.1039/c4cs00155a.10.1039/c4cs00155a ↗
51. Lv RC, Yang PP, He F, Gai SL, Li CX, Dai YL, et al. A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light. ACS Nano. 2015;9(2):1630–47. https://doi.org/10.1021/nn5063613.10.1021/nn5063613 ↗
52. Liu B, Li CX, Chen GY, Liu B, Deng XR, Wei Y, et al. Synthesis and optimization of MoS2@Fe3O4-ICG/Pt(IV) nanoflowers for MR/IR/PA bioimaging and combined PTT/PDT/chemotherapy triggered by 808 nm laser. Adv Sci. 2017. https://doi.org/10.1002/advs.201600540.10.1002/advs.201600540 ↗
53. Feng LL, He F, Liu B, Yang GX, Gai SL, Yang PP, et al. g-C3N4 coated upconversion nanoparticles for 808 nm near-infrared light triggered phototherapy and multiple imaging. Chem Mater. 2016;28(21):7935–46. https://doi.org/10.1021/acs.chemmater.6b03598.10.1021/acs.chemmater.6b03598 ↗
54. Wang HJ, Dong CH, Zhao PQ, Wang S, Liu ZY, Chang J. Lipid coated upconverting nanoparticles as NIR remote controlled transducer for simultaneous photodynamic therapy and cell imaging. Int J Pharm. 2014;466(1–2):307–13. https://doi.org/10.1016/j.ijpharm.2014.03.029.10.1016/j.ijpharm.2014.03.029 ↗
55. Wu CS, Cui MH, Cai L, Chen C, Zhu XH, Wu YH, et al. NIR-responsive photodynamic nanosystem combined with antitumor immune optogenetics bacteria for precise synergetic therapy. ACS Appl Mater Interfaces. 2022;14(11):13094–106. https://doi.org/10.1021/acsami.2c01138.10.1021/acsami.2c01138 ↗
56. Wang S, Yang WT, Cui J, Li X, Dou Y, Su L, et al. pH- and NIR light responsive nanocarriers for combination treatment of chemotherapy and photodynamic therapy. Biomater Sci. 2016;4(2):338–45. https://doi.org/10.1039/c5bm00328h.10.1039/c5bm00328h ↗
57. Liu B, Li CX, Yang PP, Hou ZY, Lin J. 808-nm-light-excited lanthanide-doped nanoparticles: rational design, luminescence control and theranostic applications. Adv Mater. 2017;29(18):1605434. https://doi.org/10.1002/adma.201605434.10.1002/adma.201605434 ↗
58. Yan J, Li B, Yang PP, Lin J, Dai YL. Progress in light‐responsive lanthanide nanoparticles toward deep tumor theranostics. Adv Funct Mater. 2021. https://doi.org/10.1002/adfm.202104325.10.1002/adfm.202104325 ↗
59. Deng KR, Li CX, Huang SS, Xing BG, Jin DY, Zeng QG, et al. Recent progress in near infrared light triggered photodynamic therapy. Small. 2017. https://doi.org/10.1002/smll.201702299.10.1002/smll.201702299 ↗
60. Chen GY, Liu HC, Somesfalean G, Sheng YQ, Liang HJ, Zhang ZG, et al. Enhancement of the upconversion radiation in Y2O3:Er3+ nanocrystals by codoping with Li+ ions. Appl Phys Lett. 2008. https://doi.org/10.1063/1.2901039.10.1063/1.2901039 ↗
61. Chen GY, Somesfalean G, Zhang ZG, Sun Q, Wang EP. Ultraviolet upconversion fluorescence in rare-earth-ion-doped Y2O3 induced by infrared diode laser excitation. Opt Lett. 2007;32(1):87–9. https://doi.org/10.1364/OL.32.000087.10.1364/OL.32.000087 ↗
62. Liu L, Shi JP, Peng SS, Zhong HY, Lin P, Wang JY, et al. Biodegradable near-infrared-IIb lanthanide-doped inorganic nanoparticles with red up-conversion luminescence for bioimaging and photodynamic therapy. Sci China Mater. 2023;66(7):2893–901. https://doi.org/10.1007/s40843-022-2404-0.10.1007/s40843-022-2404-0 ↗
63. Zhou SS, Ke JX, Lei YC, Ye LX, Liu YS, Hong MC. Highly efficient lanthanide‐doped theranostic nanoplatform for real‐time monitoring of direct triplet‐sensitized photodynamic therapy. BMC Nurs. 2025. https://doi.org/10.1007/s12598-025-03340-9.10.1007/s12598-025-03340-9 ↗
64. Wang JF, Ping SG, Lin M, Fu LB, Liu YS, Han LL, et al. Dual-site fo’’rster resonance energy transfer route of upconversion nanoparticles-based brain-targeted nanotheranostic boosts the near-infrared phototherapy of glioma. ACS Nano. 2023;17(17):16840–53. https://doi.org/10.1021/acsnano.3c03724.10.1021/acsnano.3c03724 ↗
65. Sedlmeier A, Gorris HH. Surface modification and characterization of photon-upconverting nanoparticles for bioanalytical applications. Chem Soc Rev. 2015;44(6):1526–60. https://doi.org/10.1039/c4cs00186a.10.1039/c4cs00186a ↗
66. Sun LN, Wei RY, Feng J, Zhang HJ. Tailored lanthanide-doped upconversion nanoparticles and their promising bioapplication prospects. Coord Chem Rev. 2018;364:10–32. https://doi.org/10.1016/j.ccr.2018.03.007.10.1016/j.ccr.2018.03.007 ↗
67. Ostrowski AD, Chan EM, Gargas DJ, Katz EM, Han G, Schuck PJ, et al. Controlled synthesis and single-particle imaging of bright, sub-10 nm lanthanide-doped upconverting nanocrystals. ACS Nano. 2012;6(3):2686–92. https://doi.org/10.1021/nn3000737.10.1021/nn3000737 ↗
68. Xie XJ, Gao NY, Deng RR, Sun Q, Xu QH, Liu XG. Mechanistic investigation of photon upconversion in Nd3+-sensitized core-shell nanoparticles. J Am Chem Soc. 2013;135(34):12608–11. https://doi.org/10.1021/ja4075002.10.1021/ja4075002 ↗
69. Ju ZY, Wang Z, Shi YQ, Xu XJ, Lv RC. Core-shell rare earth nanoparticles for photochemo-dynamic cancer theranostics under NIR excitation. ACS Appl Nano Mater. 2024;7(20):23894–906. https://doi.org/10.1021/acsanm.4c04457.10.1021/acsanm.4c04457 ↗
70. Xu FY, Zhao YM, Hu M, Zhang P, Kong N, Liu RY, et al. Lanthanide-doped core-shell nanoparticles as a multimodality platform for imaging and photodynamic therapy. Chem Commun. 2018;54(68):9525–8. https://doi.org/10.1039/c8cc05057k.10.1039/c8cc05057k ↗
71. Hou BB, Zheng B, Gong XQ, Wang HJ, Wang S, Liao ZY, et al. A UCN@mSiO2@cross-linked lipid with high steric stability as a NIR remote controlled-release nanocarrier for photodynamic therapy. J Mater Chem B Mater Biol Med. 2015;3(17):3531–40. https://doi.org/10.1039/c5tb00240k.10.1039/c5tb00240k ↗
72. Liang LE, Care A, Zhang R, Lu YQ, Packer NH, Sunna A, et al. Facile assembly of functional upconversion nanoparticles for targeted cancer imaging and photodynamic therapy. ACS Appl Mater Interfaces. 2016;8(19):11945–53. https://doi.org/10.1021/acsami.6b00713.10.1021/acsami.6b00713 ↗
73. Wu X, Zhang YW, Takle K, Bilsel O, Li ZJ, Lee H, et al. Dye-sensitized core/active shell upconversion nanoparticles for optogenetics and bioimaging applications. ACS Nano. 2016;10(1):1060–6. https://doi.org/10.1021/acsnano.5b06383.10.1021/acsnano.5b06383 ↗
74. Wang JR, Liu M, Wang JW, Li ZY, Feng ZH, Xu MQ, et al. Zinc oxide nanoparticles with catalase-like nanozyme activity and near-infrared light response: a combination of effective photodynamic therapy, autophagy, ferroptosis, and antitumor immunity. Acta Pharm Sin B. 2024;14(10):4493–508. https://doi.org/10.1016/j.apsb.2024.07.002.10.1016/j.apsb.2024.07.002 ↗
75. Shapoval O, Vetvicka D, Patsula V, Engstová H, Kocková O, Konefal M, et al. Temoporfin-conjugated upconversion nanoparticles for nir-induced photodynamic therapy: studies with pancreatic adenocarcinoma cells in vitro and in vivo. Pharmaceutics. 2023;15(12):2694. https://doi.org/10.3390/pharmaceutics15122694.10.3390/pharmaceutics15122694 ↗
76. Juengpanich S, Li SJ, Yang TR, Xie TA, Chen JD, Shan YK, et al. Pre-activated nanoparticles with persistent luminescence for deep tumor photodynamic therapy in gallbladder cancer. Nat Commun. 2023. https://doi.org/10.1038/s41467-023-41389-1.10.1038/s41467-023-41389-1 ↗
77. Han RL, Tang KQ, Hou YF, Yu JC, Wang CL, Wang Y. Ultralow-intensity near infrared light synchronously activated collaborative chemo/photothermal/photodynamic therapy. Biomater Sci. 2020;8(2):607–18. https://doi.org/10.1039/c9bm01607d.10.1039/c9bm01607d ↗
78. Ghorpade KB, Kumar M, Tiwari S. A review on composites based on upconversion nanoparticles and graphene oxide: development and theranostic applications centered at solid tumors. J Mater Sci Mater Eng. 2024. https://doi.org/10.1186/s40712-024-00187-3.10.1186/s40712-024-00187-3 ↗
79. Hamblin MR. Upconversion in photodynamic therapy: plumbing the depths. Dalton Trans. 2018;47(26):8571–80. https://doi.org/10.1039/c8dt00087e.10.1039/c8dt00087e ↗
80. Garfield DJ, Borys NJ, Hamed SM, Torquato NA, Tajon CA, Tian B, et al. Enrichment of molecular antenna triplets amplifies upconverting nanoparticle emission. Nat Photon. 2018;12(7):402–7. https://doi.org/10.1038/s41566-018-0156-x.10.1038/s41566-018-0156-x ↗
81. Ansari AAA, Parchur AKK, Chen GY. Surface modified lanthanide upconversion nanoparticles for drug delivery, cellular uptake mechanism, and current challenges in NIR-driven therapies. Coord Chem Rev. 2022. https://doi.org/10.1016/j.ccr.2022.214423.10.1016/j.ccr.2022.214423 ↗
82. Qiao XF, Zhou JC, Xiao JW, Wang YF, Sun LD, Yan CH. Triple-functional core-shell structured upconversion luminescent nanoparticles covalently grafted with photosensitizer for luminescent, magnetic resonance imaging and photodynamic therapy in vitro. Nanoscale. 2012;4(15):4611–23. https://doi.org/10.1039/c2nr30938f.10.1039/c2nr30938f ↗
83. Oldenburg M, Turshatov A, Busko D, Wollgarten S, Adams M, Baroni N, et al. Photon upconversion at crystalline organic-organic heterojunctions. Adv Mater. 2016;28(38):8477–82. https://doi.org/10.1002/adma.201601718.10.1002/adma.201601718 ↗
84. Tsang CY, Zhang Y. Nanomaterials for light-mediated therapeutics in deep tissue. Chem Soc Rev. 2024. https://doi.org/10.1039/d3cs00862b.10.1039/d3cs00862b ↗
85. Li YB, Jiang MY, Deng ZM, Zeng SJ, Hao JH. Low dose soft X-ray remotely triggered lanthanide nanovaccine for deep tissue CO gas release and activation of systemic anti-tumor immunoresponse. Adv Sci. 2021. https://doi.org/10.1002/advs.202004391.10.1002/advs.202004391 ↗
86. Shen YZ, Shuhendler AJ, Ye DJ, Xu JJ, Chen HY. Two-photon excitation nanoparticles for photodynamic therapy. Chem Soc Rev. 2016;45(24):6725–41. https://doi.org/10.1039/c6cs00442c.10.1039/c6cs00442c ↗
87. Ogawa K, Kobuke Y. Recent advances in two-photon photodynamic therapy. Anticancer Agents Med Chem. 2008;8(3):269–79. https://doi.org/10.2174/187152008783961860.10.2174/187152008783961860 ↗
88. Yi GS, Chow GM. Water-soluble NaYF4:Yb,Er(Tm)/NaYF4/Polymer core/shell/shell nanoparticles with significant enhancement of upconversion fluorescence. Chem Mater. 2007;19(3):341–3. https://doi.org/10.1021/cm062447y.10.1021/cm062447y ↗
89. Zhao J, Hu YB, Lin SW, Resch-Genger U, Zhang R, Wen J, et al. Enhanced luminescence intensity of near-infrared-sensitized upconversion nanoparticles via Ca2+ doping for a nitric oxide release platform. J Mater Chem B. 2020;8(30):6481–9. https://doi.org/10.1039/d0tb00088d.10.1039/d0tb00088d ↗
90. Tang M, Zhu XH, Zhang YH, Zhang ZP, Zhang ZM, Mei QS, et al. Near-infrared excited orthogonal emissive upconversion nanoparticles for imaging-guided on-demand therapy. ACS Nano. 2019;13(9):10405–18. https://doi.org/10.1021/acsnano.9b04200.10.1021/acsnano.9b04200 ↗
91. Jin GR, He RY, Liu Q, Lin M, Dong YQ, Li K, et al. Near-infrared light-regulated cancer theranostic nanoplatform based on aggregation-induced emission luminogen encapsulated upconversion nanoparticles. Theranostics. 2019;9(1):246–64. https://doi.org/10.7150/thno.30174.10.7150/thno.30174 ↗
92. Han JH, Xu XY, Jin FY, Xu XL, Fang T, Du YZ. Tumor oxygenation nanoliposomes promote deep photodynamic therapy for triple-negative breast cancer. Biomater Sci. 2024;12(19):4967–79. https://doi.org/10.1039/d4bm00847b.10.1039/d4bm00847b ↗
93. Mondal T, Sahoo P, Nandi SK, Kundu S, Li ML, Haldar N, et al. Opto-magnetic optimization enhances the multimodal therapeutic and diagnostic (UCL/T1–T2W MRI) potential of GdOF against MDA-MB-231. J Mater Chem B. 2025;13(32):9993–10008. https://doi.org/10.1039/d5tb01151e.10.1039/d5tb01151e ↗
94. Deepak KGK, Vempati R, Nagaraju GP, Dasari VR, Nagini S, Rao DN, et al. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683. https://doi.org/10.1016/j.phrs.2020.104683.10.1016/j.phrs.2020.104683 ↗
95. Simon-Yarza T, Mielcarek A, Couvreur P, Serre C. Nanoparticles of metal‐organic frameworks: on the road to in vivo efficacy in biomedicine. Adv Mater. 2018. https://doi.org/10.1002/adma.201707365.10.1002/adma.201707365 ↗
96. Chen JM, Fan TJ, Xie ZJ, Zeng QQ, Xue P, Zheng TT, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials. 2020. https://doi.org/10.1016/j.biomaterials.2020.119827.10.1016/j.biomaterials.2020.119827 ↗
97. Guo L, Wang M, Cao DP. A novel Zr‐MOF as fluorescence turn‐on probe for real‐time detecting H2S gas and fingerprint identification. Small. 2018. https://doi.org/10.1002/smll.201703822.10.1002/smll.201703822 ↗
98. Park J, Xu M, Li FY, Zhou HC. 3D long-range triplet migration in a water-stable metal-organic framework for upconversion-based ultralow-power in vivo imaging. J Am Chem Soc. 2018;140(16):5493–9. https://doi.org/10.1021/jacs.8b01613.10.1021/jacs.8b01613 ↗
99. Lv ZJ, Cao Y, Xue DZ, Zhang H, Zhou SJ, Yin N, et al. A multiphoton transition activated iron based metal organic framework for synergistic therapy of photodynamic therapy/chemodynamic therapy/chemotherapy for orthotopic gliomas. J Mater Chem B. 2023;11(5):1100–7. https://doi.org/10.1039/d2tb02273g.10.1039/d2tb02273g ↗
100. Chen Y, Li DQ, Zhong YP, Lu ZT, Wang D. NIR regulated upconversion nanoparticles@metal-organic framework composite hydrogel dressing with catalase-like performance and enhanced antibacterial efficacy for accelerating wound healing. Int J Biol Macromol. 2023. https://doi.org/10.1016/j.ijbiomac.2023.123683.10.1016/j.ijbiomac.2023.123683 ↗